---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-054744"
form_type: "8-K"
ticker: "NMTC"
cik: "0001500198"
company_name: "NEUROONE MEDICAL TECHNOLOGIES Corp"
filed_at: "2026-05-12T12:10:23+00:00"
generated_at: "2026-05-12T12:19:13.583374+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NeuroOne Q2 product revenue up 72% to $2.4M; net loss narrows to $2.1M

## Summary
- Product revenue $2.4M (+72% YoY); no license revenue vs $3.0M in prior year first half.
- Net loss $2.1M ($0.25/sh) vs $2.3M ($0.44/sh) in same quarter last year.
- Cash $2.8M; working capital $5.7M; no debt outstanding; accounts receivable $2.4M.
- 16 trigeminal neuralgia cases completed with all patients reportedly pain free.
- Christopher Volker to become CFO effective July 1, 2026; David Wambeke hired as CBO.

## SEC filing metadata
- accession: 0001213900-26-054744
- form_type: 8-K
- ticker: NMTC
- cik: 0001500198
- company_name: NEUROONE MEDICAL TECHNOLOGIES Corp
- filed_at: 2026-05-12T12:10:23+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1500198/000121390026054744/0001213900-26-054744-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1500198/000121390026054744/ea0290094-8k_neuroone.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-054744
- JSON: https://secwatch.observer/filing/0001213900-26-054744.json
- Plain text: https://secwatch.observer/filing/0001213900-26-054744.txt

## Key facts
- Earnings Releases
  NEUROONE MEDICAL TECHNOLOGIES Corp reported financial results for the fiscal quarter ended March 31, 2026.
  - Period: the fiscal quarter ended March 31, 2026
  - Result: reported results
  source text: On May 12, 2026, NeuroOne Medical Technologies Corporation (the "Company") issued a press release announcing its financial results for the fiscal quarter ended March 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1500198/000121390026054744/0001213900-26-054744-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.